Show Notes
1. Strategic Actions and Decisions * Assess the $15 billion physical uranium market structure: The underlying commodity market is exceptionally thin, cash-only, and lacks liquid derivatives or futures, creating structural supply vulnerabilities despite steady global reactor growth. * Capitalize on pricing disconnects in physical contracts: Utilities are entering long-term contracts with price floors near $105/lb and caps at $130/lb, while spot prices linger around $89/lb—below greenfield mine incentive costs of $120–$130/lb. * Prepare for supply squeezes driven by policy mandates: US legislation mandating domestic uranium purchases and banning Russian enriched imports faces physical impossibilities, as current US production is only 3 million pounds against 55 million pounds of annual consumption. * Short speculative SMR and fusion ventures while favoring proven operators: Highly hyped SMR startups face massive safety, regulatory, and technical risks, making established defense/industrial suppliers with existing miniaturized reactor capabilities far more viable. * Position for sum-of-the-parts revaluation in tier-one miners: Primary uranium producers present significant asymmetric upside through overlooked asset stakes, such as pending nuclear services unit IPOs, alongside long-term physical commodity holding vehicles. Executive Summary The global nuclear fuel supply chain faces a structural supply-demand deficit driven by low utility inventories, political restrictions on Russian imports, and lengthy mine development timelines. Despite long-term fundamentals supporting substantial price increases, physical uranium and mining equities remain artificially depressed due to high interest rates, illiquid spot markets, and transient macro sentiment. Strategic opportunities exist in physical uranium holding vehicles, established tier-one miners with hidden asset value, and military-contracted nuclear engineering providers. Conversely, early-stage fusion companies and unproven small modular reactor (SMR) startups represent significant downside risk due to unviable technology and severe safety constraints. Key Takeaways and Practical Lessons * Physical supply deficits will trigger a market squeeze: The exhaustion of utility buffer inventories and impending bans on Russian nuclear imports will force utility buyers into a tight market by 2028–2029. * Build baseline allocations in physical uranium holding trusts (e.g., Sprott Uranium Trust) during periods of weakness to capture long-term supply deficit upside without operational execution risk. * Unhedged greenfield projects face economic friction: Greenfield mining projects require selling prices of $120–$130/lb to justify production, far exceeding current spot prices. * Avoid investing in unhedged, early-stage greenfield miners dependent on near-term spot pricing to fund capital expenditures. * Commercial hype in nuclear technology creates short opportunities: Venture-backed SMR startups and commercial fusion firms frequently make unrealistic timeline claims while utilizing high-risk fuel and cooling configurations. * Maintain a short bias or zero exposure toward speculative SMR/fusion pure-plays, redirecting capital toward established industrial incumbents with military track records. * Sum-of-the-parts mispricings offer margin of safety: Market mispricings occur when major miners hold hidden or equity-accounted stakes in auxiliary nuclear infrastructure units. * Target large-cap uranium producers where non-consolidated holdings (e.g., reactor service providers) cover a dominant portion of the enterprise valuation. * Product tanker tightness driven by global refined fuel imbalances: Supply chain disruptions and regional refinery closures have created severe supply bottlenecks for refined products like diesel and jet fuel. * Overweight product tanker shipping fleets and offshore oil service providers over unhedged land drillers or unprofitable renewable energy equities.
🔗 Renaud’s
More from The Noble Update Podcast
All it takes to break the AI picks and shovels trade is order growth slowing from 30% to 15%. That's STILL double-digit growth, but the stocks can get crushed anyway.
Last week CoreWeave's bonds traded at yields around 15%, and the cost of insuring its debt implied roughly a 60% chance of default within 5 years. Oracle's default insurance hit a record high at the same time. That's what it looks like when narratives and dreams run into a lack of cash flow and a mountain of debt.
This is the final episode of our series with Tom Gober. Last episode ended with Tom challenging the offshore reinsurers to show us the $1.5 trillion, and in Episode 4, he shows you which companies are behind it. Just 40 companies account for 85% of it, and the biggest sends $235.7 billion to a single offshore affiliate while holding only $4 billion of surplus, which Tom describes as moving money from one pocket to another, like "trust me, bro, I got this."
Last episode, we left off with Tom Gober about to reveal a secret document he found in a company president’s personal files, and Episode 3 opens with what it said. A CFO in a criminal case was recorded calling these offshore deals “a little bit like morphine,” and Tom explains why: once you start, the hole gets bigger and you need a bigger dose. Here’s what we’re going over in Episode 3 “The Secret Side Letter”: * Tom tells you what was in the side letter hidden behind a reinsurance contract that looked perfect to an examiner, from a case that sent the man in control to prison for 18 and a half years, and you’ll hear what happened when the FBI knocked on his door in Del Mar. * Tom puts the cushion of the entire US life and annuity industry at about $650 billion, and he says more than that sits in secret captives alone, while more than $1 trillion has gone offshore, out of sight. * Tom shows what happened at a big insurance group after KKR took it over from Goldman Sachs, including a carrier with about $3.7 billion in affiliated investments sitting on roughly $200 million of surplus, where a 6% haircut would wipe out its entire surplus. * Big institutions hold more than $500 billion of short-term notes issued through these insurers, and at one of those companies, a legal opinion puts those investors on equal footing with policyholders like you, which Tom says means they’ll see trouble coming first and get to the exit before you do. Tom also names the two insurers he loves, so stay for that. In my world, if you sell a stock through one broker and buy it right back through another, that’s painting the tape, and you’re not allowed to do it because it kills true price discovery. When the same owner sits on both sides of an insurance company’s investments, it looks eerily similar to me. Tom ends this one with a simple message for the offshore reinsurers and secret captives: if the $1.5 trillion is really there, show us.
Our long/short spread widened to 67.4% today, with our longs up 25.9% on average and our shorts down 41.6%.